Latest Capital Structure News

Eden Innovations Ltd trimmed its loss to $5 million in FY2026 while erasing bank debt and converting loans into equity, supported by property sales and capital raises.

Pengana International Equities (ASX: PIA) posted a sharp 82% plunge in net profit for FY26, triggering a strategic board reshuffle and a capital management package including a special dividend and buy-back proposal.

Adherium's FY2026 results show strong revenue gains from US remote patient monitoring but increased losses due to higher operating costs and commercial expansion.

Carnaby Resources secures ASX waiver to cancel 5.52 million unlisted options for $835,000 cash without shareholder approval, clearing a key hurdle in Evolution Mining's takeover scheme.

Asara Resources has more than doubled its Kada Gold Project resource to 2.1 million ounces, including 1.3 million ounces in the indicated category, following a 73,000-metre drilling campaign. The company is fully funded to complete a Definitive Feasibility Study by mid-2027, positioning itself for rapid development in Guinea’s prolific Siguiri Basin.

West Wits Mining has transitioned from developer to producer with first gold poured at Qala Shallows, backed by a $97 million project finance package and a resource base expanded to 7.24 million ounces.

KKR Credit Income Fund has released the audited financial statements for its core investments as of December 31, 2025, revealing mixed returns and ongoing portfolio adjustments across multiple funds.

Orion Equities (ASX:OEQ) returned to profitability in FY26 with a $204,000 net profit, buoyed by a $400,000 uplift in investment property value. Despite a 7% dip in total revenue, net tangible asset backing per share edged up to $0.43, while no dividend was declared.

Alterity Therapeutics posted a 285% jump in revenue to A$1.72 million but also a 93% rise in net loss to A$23.4 million for FY2026. The company secured FDA alignment on a single pivotal Phase 3 trial for ATH434 in Multiple System Atrophy, setting the stage for trial start by year-end.

Tartana Minerals has lodged a cleansing prospectus to enable ASX quotation of over 129 million options linked to a $4.5 million placement, with exercise price set at 5.5 cents and expiry in April 2029.

Argo Global Listed Infrastructure Limited has renewed its on-market buy-back facility for another year, allowing up to 9.4 million shares to be repurchased as part of ongoing capital management.

Pengana Capital Group (ASX:PCG) has initiated an on-market buy-back program targeting nearly 10% of its issued ordinary shares, signaling a strategic move in capital management without requiring shareholder approval.